Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
In this video, MeiLan K. Han, MD, MS, explains her decision-making process for determining the risk/reward of performing imaging for the identification of COPD, calling it a "delicate balance." It is a...